|
US4404207A
(en)
|
1981-11-06 |
1983-09-13 |
Riker Laboratories, Inc. |
Antimicrobial 8-substituted benzo [IJ]quinolizines
|
|
US5138089A
(en)
*
|
1986-06-27 |
1992-08-11 |
The Procter & Gamble Company |
Chromophores, sunscreen compositions and methods for preventing sunburn
|
|
WO1995020589A1
(en)
|
1994-01-28 |
1995-08-03 |
Cell Therapeutics, Inc. |
Cell signaling inhibitors
|
|
US6011029A
(en)
|
1996-02-26 |
2000-01-04 |
Bristol-Myers Squibb Company |
Inhibitors of farnesyl protein transferase
|
|
US6455564B1
(en)
|
1999-01-06 |
2002-09-24 |
Pharmacia & Upjohn Company |
Method of treating sexual disturbances
|
|
US7101869B2
(en)
|
1999-11-30 |
2006-09-05 |
Pfizer Inc. |
2,4-diaminopyrimidine compounds useful as immunosuppressants
|
|
US7345051B2
(en)
|
2000-01-31 |
2008-03-18 |
Genaera Corporation |
Mucin synthesis inhibitors
|
|
EP1339812B1
(en)
|
2000-11-20 |
2008-07-16 |
MERCK PATENT GmbH |
Chiral photoisomerizable compounds
|
|
CA2463136A1
(en)
|
2001-10-17 |
2003-04-24 |
Raymond Andersen |
Ship 1 modulators
|
|
WO2003045929A1
(en)
|
2001-11-26 |
2003-06-05 |
Takeda Chemical Industries, Ltd. |
Bicyclic derivative, process for producing the same, and use
|
|
HUP0203976A3
(en)
|
2002-11-15 |
2004-08-30 |
Sanofi Aventis |
Adenozine a3 receptors, process for their preparation and pharmaceutical compositions containing them
|
|
TWI322012B
(en)
|
2002-12-20 |
2010-03-21 |
Organon Nv |
Tetrahydroquinoline derivatives
|
|
IN2003CH00929A
(cg-RX-API-DMAC7.html)
|
2003-11-13 |
2008-10-06 |
|
|
|
WO2005066162A1
(en)
|
2003-12-23 |
2005-07-21 |
Human Biomolecular Research Institute |
Synthetic compounds and derivatives as modulators of smoking or nicotine ingestion and lung cancer
|
|
JP4790703B2
(ja)
|
2004-04-07 |
2011-10-12 |
武田薬品工業株式会社 |
環式化合物
|
|
US20060106020A1
(en)
|
2004-04-28 |
2006-05-18 |
Rodgers James D |
Tetracyclic inhibitors of Janus kinases
|
|
JP2009520038A
(ja)
|
2005-12-19 |
2009-05-21 |
ジェネンテック・インコーポレーテッド |
ピリミジンキナーゼインヒビター
|
|
US20070203236A1
(en)
|
2006-01-11 |
2007-08-30 |
Smith Jeffrey W |
Novel antagonists of the human fatty acid synthase thioesterase
|
|
AU2007249827A1
(en)
|
2006-05-09 |
2007-11-22 |
Colorado State University Research Foundation |
Methods for treating blood disorders
|
|
EP1878724A1
(en)
|
2006-07-15 |
2008-01-16 |
sanofi-aventis |
A regioselective palladium catalyzed synthesis of benzimidazoles and azabenzimidazoles
|
|
CA2574531C
(en)
|
2007-01-19 |
2016-10-25 |
The University Of British Columbia |
Hat acetylation promoters and uses of compositions thereof in promoting immunogenicity
|
|
WO2008157680A2
(en)
|
2007-06-21 |
2008-12-24 |
The Wistar Institute |
Methods and compositions for modulating p300/cbp activity
|
|
WO2009000413A1
(en)
|
2007-06-26 |
2008-12-31 |
Sanofi-Aventis |
A regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazoles
|
|
JP5223864B2
(ja)
|
2007-06-27 |
2013-06-26 |
大正製薬株式会社 |
１１β−ＨＳＤ１阻害活性を有する化合物
|
|
TW200930369A
(en)
|
2007-11-15 |
2009-07-16 |
Astrazeneca Ab |
Bis-(sulfonylamino) derivatives in therapy
|
|
AR072008A1
(es)
|
2008-06-13 |
2010-07-28 |
Merck & Co Inc |
Compuestos heterobiciclicos como agentes de inhibicion de quinasa p38
|
|
UA105005C2
(uk)
|
2008-06-16 |
2014-04-10 |
Юніверсіті Оф Теннессі Рісерч Фаундейшн |
Сполуки для лікування раку
|
|
WO2010110380A1
(ja)
*
|
2009-03-27 |
2010-09-30 |
興和株式会社 |
縮合ピペリジン化合物及びこれを含有する医薬
|
|
WO2010118208A1
(en)
|
2009-04-09 |
2010-10-14 |
Exelixis, Inc. |
Benzoxazepin-4- (5h) -yl derivatives and their use to treat cancer
|
|
AU2010237633B2
(en)
|
2009-04-15 |
2015-09-17 |
Jw Pharmaceutical Corporation |
Novel compounds of reverse-turn mimetics, method for manufacturing the same and use thereof
|
|
WO2010138490A1
(en)
|
2009-05-26 |
2010-12-02 |
Exelixis, Inc. |
Benzoxazepines as inhibitors of mtor and methods of their use and manufacture
|
|
MX2011012584A
(es)
|
2009-05-26 |
2012-02-21 |
Exelixis Inc |
Benzoxazepinas como inhibidores de pi3k/m tor, metodos para su uso y fabricación.
|
|
US9005670B2
(en)
|
2010-01-05 |
2015-04-14 |
The Johns Hopkins University |
Use of histone acetyltransferase inhibitors as novel anti-cancer therapies
|
|
CA2791738C
(en)
|
2010-03-01 |
2020-06-09 |
Gtx, Inc. |
Aryl imidazolyl compounds for the treatment of cancer
|
|
WO2011150156A2
(en)
|
2010-05-26 |
2011-12-01 |
Sunovion Pharmaceuticals Inc. |
Heteroaryl compounds and methods of use thereof
|
|
WO2012019093A1
(en)
|
2010-08-05 |
2012-02-09 |
Human Biomolecular Research Institute |
Synthetic compounds and methods to decrease nicotine self-administration
|
|
EP2651405A2
(en)
|
2010-12-14 |
2013-10-23 |
Electrophoretics Limited |
Casein kinase 1 (ck1 ) inhibitors
|
|
US8765978B2
(en)
|
2010-12-16 |
2014-07-01 |
Transitions Optical, Inc. |
Method of making indeno-fused naphthol materials
|
|
US9295754B2
(en)
|
2011-02-24 |
2016-03-29 |
Emory University |
Noggin inhibitory compositions for ossification and methods related thereto
|
|
UY34171A
(es)
|
2011-07-01 |
2013-01-31 |
Gilead Sciences Inc |
Compuestos heterocíclicos fusionados como moduladores del canal iónico
|
|
GB201111705D0
(en)
|
2011-07-07 |
2011-08-24 |
Takeda Pharmaceutical |
Compounds and their use
|
|
WO2013148114A1
(en)
|
2012-03-30 |
2013-10-03 |
University Of Florida Research Foundation, Inc. |
P300/cbp inhibitors and methods of use
|
|
US9211333B2
(en)
|
2012-06-05 |
2015-12-15 |
Hong Kong Baptist University |
Anti-cancer agents synthesized based on miliusane compounds
|
|
WO2014045305A1
(en)
|
2012-09-21 |
2014-03-27 |
Advinus Therapeutics Limited |
Substituted fused tricyclic compounds, compositions and medicinal applications thereof
|
|
RU2543485C2
(ru)
|
2013-02-26 |
2015-03-10 |
Андрей Александрович Иващенко |
Гетероциклические агонисты рецепторов желчных кислот tgr5, фармацевтическая композиция, способы их получения и применения
|
|
TWI527811B
(zh)
|
2013-05-09 |
2016-04-01 |
吉李德科學股份有限公司 |
作爲溴結構域抑制劑的苯並咪唑衍生物
|
|
KR102307566B1
(ko)
|
2013-06-21 |
2021-10-05 |
제니쓰 에피제네틱스 리미티드 |
신규한 바이사이클릭 브로모도메인 억제제
|
|
CN105473581B
(zh)
|
2013-06-21 |
2019-04-23 |
齐尼思表观遗传学有限公司 |
作为溴结构域抑制剂的新取代的双环化合物
|
|
BR112016001457A2
(pt)
|
2013-07-25 |
2017-08-29 |
Dana Farber Cancer Inst Inc |
Inibidores de fatores de transcrição e usos dos mesmos
|
|
DE102013215912B3
(de)
|
2013-08-12 |
2015-02-26 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Farbneutral beschichteter kupferhaltiger Gegenstand, Verfahren zu dessen Herstellung sowie Verwendung einer entsprechenden farbneutralen Beschichtung
|
|
UY35834A
(es)
|
2013-11-14 |
2015-05-29 |
Bristol Myers Squibb Company Una Corporación Del Estado De Delaware |
Piperazinas de pirazolo sustituido como inhibidores de caseína quinasa 1 delta y epsilon
|
|
BR122019007990B1
(pt)
|
2013-11-18 |
2021-05-04 |
Forma Therapeutics, Inc |
Composto, e, composição farmacêutica
|
|
RU2720237C2
(ru)
|
2013-11-18 |
2020-04-28 |
Форма Терапеутикс, Инк. |
Композиции, содержащие бензопиперазин, в качестве ингибиторов бромодоменов вет
|
|
CN107073125A
(zh)
|
2014-09-19 |
2017-08-18 |
基因泰克公司 |
Cbp/ep300和bet抑制剂用于治疗癌症的用途
|
|
EP3632915A1
(en)
|
2014-11-27 |
2020-04-08 |
Genentech, Inc. |
4,5,6,7-tetrahydro-1 h-pyrazolo[4,3-c]pyridin-3-amine compounds as cbp and/or ep300 inhibitors
|
|
US10435402B2
(en)
|
2015-01-08 |
2019-10-08 |
Advinus Therapeutics Limited |
Bicyclic compounds, compositions and medicinal applications thereof
|
|
WO2016128908A1
(en)
|
2015-02-12 |
2016-08-18 |
Advinus Therapeutics Limited |
Bicyclic compounds, compositions and medicinal applications thereof
|
|
GB201506660D0
(en)
|
2015-04-20 |
2015-06-03 |
Cellcentric Ltd |
Pharmaceutical compounds
|
|
GB201506658D0
(en)
|
2015-04-20 |
2015-06-03 |
Cellcentric Ltd |
Pharmaceutical compounds
|
|
WO2017197056A1
(en)
|
2016-05-10 |
2017-11-16 |
C4 Therapeutics, Inc. |
Bromodomain targeting degronimers for target protein degradation
|
|
CN109414596B
(zh)
|
2016-05-12 |
2023-09-29 |
密歇根大学董事会 |
Ash1l抑制剂和用其进行治疗的方法
|
|
WO2017205536A2
(en)
|
2016-05-24 |
2017-11-30 |
Genentech, Inc. |
Therapeutic compounds and uses thereof
|
|
GB201617630D0
(en)
|
2016-10-18 |
2016-11-30 |
Cellcentric Ltd |
Pharmaceutical compounds
|
|
GB201617627D0
(en)
|
2016-10-18 |
2016-11-30 |
Cellcentric Ltd |
Pharmaceutical compounds
|
|
US10617680B2
(en)
*
|
2017-04-18 |
2020-04-14 |
Celgene Quanticel Research, Inc. |
Therapeutic compounds
|
|
WO2019055877A1
(en)
*
|
2017-09-15 |
2019-03-21 |
Forma Therapeutics, Inc. |
TETRAHYDROIMIDAZO QUINOLINE COMPOSITIONS AS INHIBITORS OF CBP / P300
|
|
IL279734B2
(en)
*
|
2018-06-29 |
2024-11-01 |
Forma Therapeutics Inc |
Inhibiting creb binding protein (cbp)
|